PhaseRx's IPO

PhaseRx raised a round of funding on May 18, 2016. Investors include Public.

PhaseRx is an RNAi delivery technology company developing a polymer-based system that enables the systemic delivery of RNAi-based drugs and potentially other macromolecules as therapeutic products. Th…

Articles about PhaseRx's IPO: